<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03437772</url>
  </required_header>
  <id_info>
    <org_study_id>PHRC-N/2016/JLC-01</org_study_id>
    <nct_id>NCT03437772</nct_id>
  </id_info>
  <brief_title>Third Generation Cognitive Behavioural Therapy vs Treatment-as-usual for ADHD</brief_title>
  <acronym>Hyper-mCBT</acronym>
  <official_title>Third Generation Cognitive Behavioural Therapy Versus Treatment-as-usual for Attention Deficit and Hyperactivity Disorder: a Randomized, 2-parallel-group, Evaluator Blinded, Superiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that the mindfulness Cognitive Behavioral Therapy program will
      lead to a reduction in attention deficit and hyperactivity disorder symptoms, anxiety and
      depression, and improve self-confidence, emotional control, social integration and school
      results.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2018</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ADHD symptom severity</measure>
    <time_frame>baseline</time_frame>
    <description>clinical-rated ADHD rating scale (ADHDRS-PI) questionnaire; score ranges 0-54</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ADHD symptom severity</measure>
    <time_frame>Month 5</time_frame>
    <description>clinical-rated ADHD rating scale (ADHDRS-PI) questionnaire; score ranges 0-54</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ADHD symptom severity</measure>
    <time_frame>Month 8</time_frame>
    <description>clinical-rated ADHD rating scale (ADHDRS-PI) questionnaire; score ranges 0-54</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parenting styles</measure>
    <time_frame>Baseline</time_frame>
    <description>Parental Authority Questionnaire (PAQ); 30 items per parent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parenting styles</measure>
    <time_frame>Month 5</time_frame>
    <description>Parental Authority Questionnaire (PAQ); 30 items per parent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parenting styles</measure>
    <time_frame>Month 8</time_frame>
    <description>Parental Authority Questionnaire (PAQ); 30 items per parent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The quality of life for parents.</measure>
    <time_frame>Baseline</time_frame>
    <description>Parental - Developmental Disorders - Quality of Life (PAR-DD-QoL) questionnaire; score ranges from 17-85</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The quality of life for parents.</measure>
    <time_frame>Month 5</time_frame>
    <description>Parental - Developmental Disorders - Quality of Life (PAR-DD-QoL) questionnaire; score ranges from 17-85</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The quality of life for parents.</measure>
    <time_frame>Month 8</time_frame>
    <description>Parental - Developmental Disorders - Quality of Life (PAR-DD-QoL) questionnaire; score ranges from 17-85</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global function</measure>
    <time_frame>Baseline</time_frame>
    <description>Clinical Global Impression Scale (CGI-S) questionnaire; score from 1-7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global function</measure>
    <time_frame>Month 5</time_frame>
    <description>Clinical Global Impression Scale (CGI-S) questionnaire; score from 1-7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global function</measure>
    <time_frame>Month 8</time_frame>
    <description>Clinical Global Impression Scale (CGI-S) questionnaire; score from 1-7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global function</measure>
    <time_frame>Baseline</time_frame>
    <description>Children's Global Assessment Scale CGAS) questionnaire; score ranges from 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global function</measure>
    <time_frame>Month 5</time_frame>
    <description>Children's Global Assessment Scale CGAS) questionnaire; score ranges from 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global function</measure>
    <time_frame>Month 8</time_frame>
    <description>Children's Global Assessment Scale CGAS) questionnaire; score ranges from 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social well-being and school parameters for children</measure>
    <time_frame>Baseline</time_frame>
    <description>CONNERS for school teachers; cut-off for significant behavioral problem &gt;15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social well-being and school parameters for children</measure>
    <time_frame>Month 5</time_frame>
    <description>CONNERS for school teachers; cut-off for significant behavioral problem &gt;15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social well-being and school parameters for children</measure>
    <time_frame>Month 8</time_frame>
    <description>CONNERS for school teachers; cut-off for significant behavioral problem &gt;15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety in children</measure>
    <time_frame>Baseline</time_frame>
    <description>Multidimensional Anxiety Scale for Children (MASC) questionnaire; 39-item, 4-point Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety in children</measure>
    <time_frame>Month 5</time_frame>
    <description>Multidimensional Anxiety Scale for Children (MASC) questionnaire; 39-item, 4-point Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety in children</measure>
    <time_frame>Month 8</time_frame>
    <description>Multidimensional Anxiety Scale for Children (MASC) questionnaire; 39-item, 4-point Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression in children</measure>
    <time_frame>Baseline</time_frame>
    <description>Children depression inventory (CDI) questionnaire; score ranges from 0-54</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression in children</measure>
    <time_frame>Month 5</time_frame>
    <description>Children depression inventory (CDI) questionnaire; score ranges from 0-54</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression in children</measure>
    <time_frame>Month 8</time_frame>
    <description>Children depression inventory (CDI) questionnaire; score ranges from 0-54</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression in parents</measure>
    <time_frame>Baseline</time_frame>
    <description>Hospital Anxiety and Depression Scale (HADS) questionnaire; 2 subscores each ranging from 0-21</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression in parents</measure>
    <time_frame>Month 5</time_frame>
    <description>Hospital Anxiety and Depression Scale (HADS) questionnaire; 2 subscores each ranging from 0-21</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression in parents</measure>
    <time_frame>Month 8</time_frame>
    <description>Hospital Anxiety and Depression Scale (HADS) questionnaire; 2 subscores each ranging from 0-21</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Esteem and behaviour for children.</measure>
    <time_frame>Baseline</time_frame>
    <description>Rosenberg scale; score ranges from 0-40</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Esteem and behaviour for children.</measure>
    <time_frame>Month 5</time_frame>
    <description>Rosenberg scale; score ranges from 0-40</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Esteem and behaviour for children.</measure>
    <time_frame>Month 8</time_frame>
    <description>Rosenberg scale; score ranges from 0-40</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Esteem and behaviour for children.</measure>
    <time_frame>Baseline</time_frame>
    <description>CONNERS questionnaire for parents; cut-off for significant behavioral problem &gt;15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Esteem and behaviour for children.</measure>
    <time_frame>Month 5</time_frame>
    <description>CONNERS questionnaire for parents; cut-off for significant behavioral problem &gt;15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Esteem and behaviour for children.</measure>
    <time_frame>Month 8</time_frame>
    <description>CONNERS questionnaire for parents; cut-off for significant behavioral problem &gt;15</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">744</enrollment>
  <condition>Adhd</condition>
  <arm_group>
    <arm_group_label>CBT with mindfulness</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as Usual: Barkley therapy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness Cognitive Behavioral Therapy program</intervention_name>
    <description>16 simultaneous-but-separate therapy sessions for parents and children.</description>
    <arm_group_label>CBT with mindfulness</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Families consulting for attention deficit and hyperactivity disorder
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  If deemed able, the patient must have given his/her informed and signed consent

          -  The parents (or legal guardian) of minor patients must have given their informed and
             signed consent.

          -  The patient and participating parents must be insured or beneficiary of a health
             insurance plan

          -  The patient is equal to or greater than 7 years old and less than or equal to 15 years
             old

          -  The patient presents with attention deficit and hyperactivity disorder with an
             ADHDRS-PI score &gt; 27

          -  The patient is currently not under treatment - OR - is treated with methylphenidate
             with a stable posology (not expected to vary in the near future) but remains
             symptomatic

        Exclusion Criteria:

          -  The patient is participating in, or has participated in over the past three months,
             another trial or another study that may interfere with the results or conclusion of
             the present study

          -  The patient is in an exclusion period determined by a previous study

          -  The participating parent(s) is(are) under judicial protection, or is an adult under
             guardianship

          -  It is impossible to correctly inform the patient or his/her parent or legal guardian

          -  Patients or parents refusing participation, signature of the signed consent or
             follow-up procedures

          -  Previously documented mental retardation (IQ &lt; 70) or suspicion thereof by the
             investigator

          -  The patient has already participated in cognitive behavioural therapy (individual or
             group) in the six months preceding inclusion

          -  Patients diagnosed with autism spectrum disorder, psychotic disorder or bipolar
             disorder

          -  The family has participated in a parental guidance programme in the last 6 months.

          -  The family has already participated in the present study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorge Lopez Castroman, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nimes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jorge Lopez Castroman, M.D</last_name>
    <phone>+33 (0)6.72.77.62.27</phone>
    <email>jorge.lopezcastroman@chu-nimes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CH Charles Perrens</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Manuel Bouvard</last_name>
      <email>mbouvard@ch-perrens.fr</email>
    </contact>
    <investigator>
      <last_name>Manuel Bouvard, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pierre Wertheimer</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier Revol</last_name>
      <email>olivier.revol@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier Revol, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>APHM - Hôpital Salvator</name>
      <address>
        <city>Marseille</city>
        <zip>13274</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Da Fonseca</last_name>
      <email>david.dafonseca@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>David Da Fonseca, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diane Purper-Ouakil</last_name>
      <email>d-purper_ouakil@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Diane Purper-Ouakil, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nimes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anissa Megzari</last_name>
      <phone>+33 (0)4.66.68.42.36</phone>
      <email>drc@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Jorge Lopez Castroman, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne Gramond, M.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>APHP - Hôpital Robert Debré</name>
      <address>
        <city>Paris</city>
        <zip>75935</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Richard Delorme</last_name>
      <email>richard.delorme@rdb.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Richard Delorme, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2018</study_first_submitted>
  <study_first_submitted_qc>February 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2018</study_first_posted>
  <last_update_submitted>February 19, 2018</last_update_submitted>
  <last_update_submitted_qc>February 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

